PEDS-PLAN - Pediatric Precision Laboratory Advanced Neuroblastoma Therapy- A Study Using Molecular Guided Therapy with Induction Chemotherapy followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for Subjects with Newly Diagnosed High-Risk Neuroblastoma

Sponsor:

Spectrum Health Hospitals

Sponsor Study ID:

NMTRC012

CTO #:

102438

NCT Number:

NCT02559778

Phase:

II

Protocol Type:

Treatment

Age Group:

Both

Disease Sites:

Brain and Nervous System

Study Objectives:

A prospective open label, multicenter study to evaluate the feasibility and acute toxicity of using molecularly guided therapy in combination with standard therapy followed by maintenance therapy with DFMO in subjects with newly diagnosed high risk neuroblastoma.

eConsent:

Not available

Study Documents:

Open Study Documents
(MUSC NetID required for document access)